← Eichor
Study identifier: NCT02551081 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units

Condition: Genetic Disease · Multiple Malformation · Congenital Malformation  ·  Sponsor: Children's Hospital of Fudan University

PhaseN/A
Planned participants2000
Who can joinAll sexes, N/A to 28 Days
Healthy volunteersNo

About this study

The purpose of study is to evaluate the benefits of using the Next Generation Sequencing Technology to diagnose birth defects and genetic diseases. The results from genomic sequencing can also significantly shorten the time of examination, improve the diagnosis rate, guide the clinical treatments. So the ultimate goal is individualized or personalized therapy and promote prognosis.

This description comes directly from the study's public registry record.

Talk to the study team

Wenhao Zhou, Doctor  ·  zwhchfu@126.com

Guoqiang Cheng, Doctor  ·  gqchengcm@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Children Hospital of Fudan UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02551081